The Valley Desk

ArticleCureusPublished

Tumor Lysis Syndrome Risk in Burkitt Lymphoma Versus Mantle Cell Lymphoma During Alkylating Therapy: A Propensity-Matched TriNetX Comparative Outcome Analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Drexel University College of Medicine, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Cureus
Published
Subject terms
Alkylating agents; Tumor Lysis Syndrome; Real-world Data; Mantle Cell Lymphoma (Mcl); Propensity Score Matching (Psm); Primary Burkitt Lymphoma
PubMed ID
42403839
PubMed Central ID
PMC13327842
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal